发明名称 Imidazo[1,5-c] quinazolines; a new class of GABA brain receptor ligands
摘要 Disclosed are compounds of compounds of the formula: <IMAGE> or the pharmaceutically acceptable nontoxic salts thereof wherein: X is oxygen, H2 or sulfur Y is hydrogen, or optionally substituted alkyl, alkenyl, (substituted)arylalkyl, aryl or heteroaryl, or a carbonyl group substituted with alkyl, cycloalkyl, aryl, or amino groups; W is alkyl, arylalkyl or heteroarylalkyl, where each aryl group is optionally substituted with up to two groups; or W is aryl, thienyl, pyridyl or heteroaryl, each of which is optionally substituted; and Z1, Z2, Z3, and Z4 independently represent nitrogen or C-R1 where R1 is hydrogen, halogen, hydroxy, amino, or phenyl or pyridyl optionally mono- or independently disubstituted with halogen, hydroxy, lower alkyl, or lower alkoxy, which compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists or inverse agonists for GABAa brain receptors. These compounds are useful in the diagnosis and treatment of anxiety, sleep, and seizure disorders, overdose with benzodiazepine drugs, and enhancement of memory.
申请公布号 US5792766(A) 申请公布日期 1998.08.11
申请号 US19960614878 申请日期 1996.03.13
申请人 NEUROGEN CORPORATION 发明人 CHEN, PAUL;HUTCHISON, ALAN;CAI, GUOLIN
分类号 A61K31/519;A61P25/22;C07D401/14;C07D403/14;C07D487/04;(IPC1-7):A61K31/505;C07D403/07 主分类号 A61K31/519
代理机构 代理人
主权项
地址